Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study
Authors:
- 1 March 2016
- journal article
- Published by Elsevier in Joint Bone Spine
- Vol. 83 (2) , 155-159
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonistsJournal of Translational Medicine, 2014
- Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α TherapyYonsei Medical Journal, 2014
- Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for HealthJoint Bone Spine, 2013
- Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysisSeminars in Arthritis and Rheumatism, 2013
- Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registryAnnals of the Rheumatic Diseases, 2013
- The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatmentRheumatology, 2012
- Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trialsArthritis & Rheumatism, 2011
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse eventsAnnals of the Rheumatic Diseases, 2009
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994